Ubs Group Ag Liquidia Corp Transaction History

Ubs Group Ag

$400 Billion
Q2 2024

A detailed history of Ubs Group Ag transactions in Liquidia Corp stock. As of the latest transaction made, Ubs Group Ag holds 101,627 shares of LQDA stock, worth $1.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

101,627

Previous 150,000 32.25%

Holding current value

$1.12 Million

Previous $2.21 Million 44.89%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$11.96 - $15.71 $230,947 - $303,360	19,310 Added 23.46%	101,627 $1.22 Million
Q1 2024 May 13, 2024	BUY	$11.35 - $16.73 $295,973 - $436,268	26,077 Added 46.37%	82,317 $1.21 Million
Q4 2023 Feb 09, 2024	BUY	$5.77 - $12.19 $182,181 - $384,887	31,574 Added 128.01%	56,240 $676,000
Q3 2023 Nov 09, 2023	SELL	$6.27 - $8.15 $59,909 - $77,873	-9,555 Reduced 27.92%	24,666 $156,000
Q2 2023 Aug 11, 2023	BUY	$6.63 - $9.9 $2,300 - $3,435	347 Added 1.02%	34,221 $268,000
Q1 2023 May 12, 2023	BUY	$5.72 - $7.91 $42,007 - $58,091	7,344 Added 27.68%	33,874 $234,000
Q4 2022 Feb 08, 2023	BUY	$4.68 - $6.54 $42,134 - $58,879	9,003 Added 51.37%	26,530 $168,000
Q3 2022 Nov 10, 2022	BUY	$3.73 - $8.39 $35,729 - $80,367	9,579 Added 120.52%	17,527 $96,000
Q2 2022 Aug 10, 2022	BUY	$3.37 - $7.55 $15,340 - $34,367	4,552 Added 134.04%	7,948 $35,000
Q1 2022 May 16, 2022	BUY	$5.14 - $7.38 $17,455 - $25,062	3,396 New	3,396 $24,000
Q4 2021 Feb 14, 2022	SELL	$2.71 - $5.17 $27,509 - $52,480	-10,151 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.28 - $2.95 $15,565 - $20,139	6,827 Added 205.39%	10,151 $28,000
Q2 2021 Aug 13, 2021	SELL	$2.51 - $3.11 $25,589 - $31,706	-10,195 Reduced 75.41%	3,324 $10,000
Q1 2021 May 12, 2021	BUY	$2.42 - $3.6 $21,729 - $32,324	8,979 Added 197.78%	13,519 $36,000
Q4 2020 Feb 11, 2021	BUY	$2.6 - $5.79 $10,337 - $23,021	3,976 Added 704.96%	4,540 $13,000
Q3 2020 Nov 12, 2020	SELL	$4.34 - $8.28 $25,592 - $48,827	-5,897 Reduced 91.27%	564 $3,000
Q2 2020 Jul 31, 2020	SELL	$4.86 - $11.44 $6,595 - $15,524	-1,357 Reduced 17.36%	6,461 $54,000
Q1 2020 May 01, 2020	SELL	$3.31 - $7.15 $40,713 - $87,945	-12,300 Reduced 61.14%	7,818 $37,000
Q4 2019 Feb 14, 2020	BUY	$3.07 - $5.11 $30,193 - $50,256	9,835 Added 95.64%	20,118 $86,000
Q3 2019 Nov 14, 2019	BUY	$3.29 - $8.24 $25,865 - $64,782	7,862 Added 324.74%	10,283 $37,000
Q2 2019 Aug 14, 2019	BUY	$7.92 - $11.39 $19,174 - $27,575	2,421 New	2,421 $19,000
Q1 2019 May 14, 2019	SELL	$10.82 - $21.79 $29,235 - $58,876	-2,702 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$16.38 - $37.18 $25,143 - $57,071	1,535 Added 131.53%	2,702 $59,000
Q3 2018 Nov 14, 2018	BUY	$10.96 - $28.9 $12,790 - $33,726	1,167 New	1,167 $32,000

Others Institutions Holding LQDA

# of Institutions

162

Shares Held

36M

Call Options Held

1.79M

Put Options Held

380K

View Full List

About Liquidia Corp

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $709M
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

More about LQDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account